Keywords: Indonesia, Rx and OTC markets, AIDS/HIV, Investment

Indonesia’s Rx and OTC drugs market to grow to $7.8 billion in 2019

Article | 04 December 2009

Business Monitor International's Business Environment Rating matrix for the first quarter of 2010 shows that Indonesia moves down one place to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing

Related Drugs

Ascorbic Acid

Vitamin C

Feldene

Piroxicam

Go to drug listing